Ascendis Pharma AS logo

Ascendis Pharma AS - ADR

FRA:A71 (Denmark)   ADR
€ 129.00 (0%) Nov 29
At Loss
Market Cap:
€ 7.70B ($ 8.15B)
Enterprise V:
€ 7.86B ($ 8.32B)
Volume:
160.00
Avg Vol (2M):
391.00
Trade In:

Business Description

Ascendis Pharma AS logo
Ascendis Pharma AS
NAICS : 325411 SIC : 2833
ISIN : US04351P1012

Share Class Description:

FRA:A71: ADR
Description
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
Name Current Vs Industry Vs History
Cash-To-Debt 0.79
Equity-to-Asset -0.09
Debt-to-Equity -8.1
Debt-to-EBITDA -2.94
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.03
Distress
Grey
Safe
Beneish M-Score -3
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 80.29
9-Day RSI 69.42
14-Day RSI 63.1
6-1 Month Momentum % 2.56
12-1 Month Momentum % 46.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.16
Quick Ratio 0.84
Cash Ratio 0.75
Days Inventory 1679.76
Days Sales Outstanding 41.27
Days Payable 708.56

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.7
Shareholder Yield % -2.12

Financials (Next Earnings Date:2025-02-07 Est.)

FRA:A71's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Ascendis Pharma AS Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 327.427
EPS (TTM) (€) -7.47
Beta 0.57
Volatility % 38.48
14-Day RSI 63.1
14-Day ATR (€) 2.488172
20-Day SMA (€) 119.55
12-1 Month Momentum % 46.34
52-Week Range (€) 91.5 - 147
Shares Outstanding (Mil) 59.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ascendis Pharma AS Filings

Filing Date Document Date Form
No Filing Data

Ascendis Pharma AS Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Ascendis Pharma AS Frequently Asked Questions

What is Ascendis Pharma AS(FRA:A71)'s stock price today?
The current price of FRA:A71 is €129.00. The 52 week high of FRA:A71 is €147.00 and 52 week low is €91.50.
When is next earnings date of Ascendis Pharma AS(FRA:A71)?
The next earnings date of Ascendis Pharma AS(FRA:A71) is 2025-02-07 Est..
Does Ascendis Pharma AS(FRA:A71) pay dividends? If so, how much?
Ascendis Pharma AS(FRA:A71) does not pay dividend.

Press Release

Subject Date
No Press Release